We are live on ! Find out more
PGEN icon

Precigen
PGEN

5.53 USD
+0.11
2.03%
At close Updated Jul 28, 4:00 PM EDT
Pre-market
After hours
5.54
+0.01
0.18%
1 day
2.03%
5 days
2.79%
1 month
-6.59%
3 months
37.56%
6 months
23.99%
Year to date
29.21%
1 year
250%
5 years
-2.98%
10 years
-77.42%
 

About: Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Employees: 47

Healthcare Biotechnology
0
Funds holding %
of 8,132 funds
Explore Fund Trends
–
Positive news %
Check Journalist POV
Price charts implemented using Lightweight Charts™